Evidence map›Paper›PMID 41705762›Full record

ArticleJACC. CardioOncology2026

REPLY: Pragmatic Troponin Surveillance for ICI Cardiotoxicity: Impactful Lessons From Real-World Practice.

Evaline Cheng, Maja Ivanovic, Ronald Witteles, Sarah Waliany, Han Zhu

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. CardioOncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Evaline ChengStanford University School of Medicine, Stanford, California, USA.
Maja IvanovicUniversity of Chicago School of Medicine, Chicago, Illinois, USA.
Ronald WittelesStanford University School of Medicine, Stanford, California, USA.
Sarah WalianyMassachusetts General Hospital, Boston, Massachusetts, USA.
Han ZhuStanford University School of Medicine, Stanford, California, USA. Electronic address: hanzhu@stanford.edu.

Funding

Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingR01HL174432 · NHLBI · STANFORD UNIVERSITY · PI Han Zhu · 2024 to 2026
$2.2M
A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 BlockadeR01HL177581 · NHLBI · STANFORD UNIVERSITY · PI Han Zhu · 2025 to 2026
$1.5M
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced MyocarditisK08HL161405 · NHLBI · STANFORD UNIVERSITY · PI Han Zhu · 2022 to 2026
$880k
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisR03HL173146 · NHLBI · STANFORD UNIVERSITY · PI ZHU, HAN · 2024 to 2025
$236k
NHLBI NIH HHS K08 HL161405NHLBI NIH HHS R01 HL174432NHLBI NIH HHS R01 HL177581NHLBI NIH HHS R03 HL173146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41705762
PMCPMC12922607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.